These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12101266

  • 41. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F, Maconi M, Albertazzi L, Gamberi B, Gugliotta L, Brini M.
    Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
    [Abstract] [Full Text] [Related]

  • 42. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
    Morelli S, Alama A, Quattrone A, Gong L, Copreni E, Canti G, Nicolin A.
    Anticancer Drug Des; 1996 Jan; 11(1):1-14. PubMed ID: 8639245
    [Abstract] [Full Text] [Related]

  • 43. [The toxic effects of high-dose Bcl-2 antisense phosphorothioate oligodeoxynucleotides incubation on cell line].
    Lin Y, Lü L, Chen Z.
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):694-7. PubMed ID: 11798838
    [Abstract] [Full Text] [Related]

  • 44. [Inhibitive effect of bcl-2 antisense oligodeoxynucleotide on Bcl-2 protein synthesis and cell proliferation in human laryngocarcinoma Hep-2 cells].
    Jing H, Huang W, Qiu J.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Feb; 33(1):17-20. PubMed ID: 11498881
    [Abstract] [Full Text] [Related]

  • 45. Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells.
    Wu CC, Castro JE, Motta M, Cottam HB, Kyburz D, Kipps TJ, Corr M, Carson DA.
    Hum Gene Ther; 2003 Jun 10; 14(9):849-60. PubMed ID: 12828856
    [Abstract] [Full Text] [Related]

  • 46. In vitro modulation of bcl-2 protein expression, drug-induced apoptosis and cytotoxicity by interleukin-10 in chronic lymphocytic leukemia.
    Morabito F, Filangeri M, Sculli G, Oliva B.
    Haematologica; 1998 Nov 10; 83(11):1046-8. PubMed ID: 9864930
    [Abstract] [Full Text] [Related]

  • 47. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, Chen W.
    Blood; 2010 Jun 17; 115(24):5041-52. PubMed ID: 20339095
    [Abstract] [Full Text] [Related]

  • 48. Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells.
    Pepper C, Hooper K, Thomas A, Hoy T, Bentley P.
    Leuk Lymphoma; 2001 Jul 17; 42(3):491-8. PubMed ID: 11699414
    [Abstract] [Full Text] [Related]

  • 49. Cationic lipids enhanced cellular uptake and activity of bcl-2 antisense oligodeoxynucleotide G3139 in HL-60 cells.
    Zhu YG, Zhuo GS, Chen ZZ, Chen XC.
    Acta Pharmacol Sin; 2001 Nov 17; 22(11):1007-12. PubMed ID: 11749792
    [Abstract] [Full Text] [Related]

  • 50. Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression.
    Chi KC, Wallis AE, Lee CH, De Menezes DL, Sartor J, Dragowska WH, Mayer LD.
    Breast Cancer Res Treat; 2000 Oct 17; 63(3):199-212. PubMed ID: 11110054
    [Abstract] [Full Text] [Related]

  • 51. Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells.
    Du HY, Xia SY, Song HF, Li N, Shang MM, Zou J, Wang QQ, Ou L, Sun X, Ji AG, Tang ZM.
    Acta Pharmacol Sin; 2007 Oct 17; 28(10):1637-44. PubMed ID: 17883951
    [Abstract] [Full Text] [Related]

  • 52. Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.
    Secchiero P, Melloni E, Tiribelli M, Gonelli A, Zauli G.
    J Leukoc Biol; 2008 Feb 17; 83(2):434-7. PubMed ID: 17998303
    [Abstract] [Full Text] [Related]

  • 53. Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides.
    Decker T, Hipp S, Kreitman RJ, Pastan I, Peschel C, Licht T.
    Blood; 2002 Feb 15; 99(4):1320-6. PubMed ID: 11830482
    [Abstract] [Full Text] [Related]

  • 54. The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
    Tarnani M, Laurenti L, Longo PG, Piccirillo N, Gobessi S, Mannocci A, Marietti S, Sica S, Leone G, Efremov DG.
    Leuk Res; 2010 Sep 15; 34(9):1189-94. PubMed ID: 20074801
    [Abstract] [Full Text] [Related]

  • 55. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: mechanistic studies.
    Manzel L, Strekowski L, Ismail FM, Smith JC, Macfarlane DE.
    J Pharmacol Exp Ther; 1999 Dec 15; 291(3):1337-47. PubMed ID: 10565859
    [Abstract] [Full Text] [Related]

  • 56. [Increase in thermosensitivity of cervical cancer and ovarian cancer cells by HSP70 antisense oligodeoxynucleotides].
    Zhao X, Wei Y.
    Zhonghua Zhong Liu Za Zhi; 2000 Mar 15; 22(2):99-101. PubMed ID: 11776656
    [Abstract] [Full Text] [Related]

  • 57. Inhibition of thymidylate synthase activity by antisense oligodeoxynucleotide and possible role in thymineless treatment.
    Lin SB, Ts'o PO, Sun SK, Choo KB, Yang FY, Lim YP, Tsai HL, Au LC.
    Mol Pharmacol; 2001 Sep 15; 60(3):474-9. PubMed ID: 11502877
    [Abstract] [Full Text] [Related]

  • 58. Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity.
    Jahrsdörfer B, Wooldridge JE, Blackwell SE, Taylor CM, Link BK, Weiner GJ.
    Leukemia; 2005 May 15; 19(5):759-66. PubMed ID: 15759034
    [Abstract] [Full Text] [Related]

  • 59. Effect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells.
    Decker T, Peschel C.
    Leuk Lymphoma; 2001 Jul 15; 42(3):301-7. PubMed ID: 11699394
    [Abstract] [Full Text] [Related]

  • 60. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA, Zangemeister-Wittke U.
    J Natl Cancer Inst; 1997 Jul 16; 89(14):1027-36. PubMed ID: 9230884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.